首站-论文投稿智能助手
典型文献
A pair of SARS-CoV-2 nucleocapsid protein monoclonal antibodies shows high specificity and sensitivity for diagnosis
文献摘要:
Dear Editor, Severe Acute Respiratory Syndrome Coronavirus Type 2(SARS-CoV-2)is the pathogen of the coronavirus disease 2019(COVID-19),which has spread worldwide. SARS-CoV-2 is an enveloped virus belongs to the family of p-coro-navirus(Xu et al.,2020).Its genome is a linear single-stranded pos-itive-sense RNA about 30,000 nucleotides packed inside a virion with a diameter of 100 nm and a volume of about 106 nm3(Bar-On et al.,2020).The genome of SARS-CoV-2 encodes 29 proteins,including 16 nonstructural,four structural,and nine accessory proteins(Bai et al.,2021).The four structural proteins are spike(S)glycoprotein,envelope(E)protein,membrane(M)protein,and nucleocapsid(N)protein(Naqvi et al.,2020),which are shared with other coronaviruses(Brian and Baric,2005;Fehr and Perlman,2015).S glycoprotein is essential for viral infection while N protein facilitates viral RNA packing,replication,virion assembly,and release(Almazán et al.,2004;Peng et al.,2020).SARS-CoV-2 has 96%identity to bats coronaviruses and 91%identity to pangolins coronaviruses in nucleic acid sequence.In contrast,its nucle-otide homology to SARS-CoV-1 is 80%,to Middle East Respiratory Syn-drome(MERS)Coronavirus(MERS-CoV)is 55%(Bar-On et al.,2020;Zhou et al.,2020).Due to its error-prone RNA dependent RNA poly-merase(RdRp),mutation rate of SARS-CoV-2 is relatively high(Ludwig and Zarbock,2020).Accordingly,multiple strains of SARS-CoV-2 have emerged,such as Alpha,Beta,Gamma,Delta,and Omicron,etc.
文献关键词:
作者姓名:
An-Kai Zhu;Sa-Sa Li;Shu-Pei Yu;Zhao-Yong Zhang;Huan Li;Jing-Feng Li;Shan-Shan Gao;Heng Chen;Jincun Zhao;Run Shi;Mingjian Lu;Chaoyang Li
作者机构:
Affiliated Cancer Hospital and Institute of Guangzhou Medical University,State Key Laboratory of Respiratory Disease,Key Laboratory for Cell Homeostasis and Cancer Research of Guangdong High Education Institute,Guangzhou,510095,China;State Key Laboratory of Respiratory Disease,National Clinical Research Center for Respiratory Disease,Guangzhou Institute of Respiratory Health,The First Affiliated Hospital of Guangzhou Medical University,Guangzhou,510182,China;Department of Interventional Radiology,Affiliated Cancer Hospital and Institute of Guangzhou Medical University,Guangzhou,510095,China
文献出处:
引用格式:
[1]An-Kai Zhu;Sa-Sa Li;Shu-Pei Yu;Zhao-Yong Zhang;Huan Li;Jing-Feng Li;Shan-Shan Gao;Heng Chen;Jincun Zhao;Run Shi;Mingjian Lu;Chaoyang Li-.A pair of SARS-CoV-2 nucleocapsid protein monoclonal antibodies shows high specificity and sensitivity for diagnosis)[J].中国病毒学,2022(06):942-945
A类:
SARS,Naqvi,Baric,Fehr,Perlman,Almaz,pangolins,Zarbock
B类:
pair,CoV,nucleocapsid,monoclonal,antibodies,shows,high,specificity,sensitivity,diagnosis,Dear,Editor, Severe,Acute,Respiratory,Syndrome,Coronavirus,Type,pathogen,disease,which,has,spread,worldwide,enveloped,belongs,family,Xu,Its,genome,linear,single,stranded,pos,itive,sense,about,nucleotides,packed,inside,virion,diameter,volume,nm3,On,encodes,proteins,including,nonstructural,four,nine,accessory,Bai,spike,glycoprotein,membrane,shared,other,coronaviruses,Brian,essential,viral,infection,while,facilitates,packing,replication,assembly,release,Peng,identity,bats,nucleic,acid,sequence,In,contrast,its,homology,Middle,East,MERS,Zhou,Due,error,prone,dependent,poly,merase,RdRp,mutation,rate,relatively,Ludwig,Accordingly,multiple,strains,have,emerged,such,Alpha,Beta,Gamma,Delta,Omicron,etc
AB值:
0.518995
相似文献
Comprehensive analysis of RNA-seq and whole genome sequencing data reveals no evidence for SARS-CoV-2 integrating into host genome
Yu-Sheng Chen;Shuaiyao Lu;Bing Zhang;Tingfu Du;Wen-Jie Li;Meng Lei;Yanan Zhou;Yong Zhang;Penghui Liu;Yong-Qiao Sun;Yong-Liang Zhao;Ying Yang;Xiaozhong Peng;Yun-Gui Yang-CAS Key Laboratory of Genomic and Precision Medicine,Col-laborative Innovation Center of Genetics and Development,College of Future Technology,Beijing Institute of Genomics,Chinese Academy of Sciences,Beijing 100101,China;China National Center for Bioinformation,Beijing 100101,China;Institute of Stem Cell and Regeneration,Chinese Academy of Sciences,Beijing 100101,China;National Kunming High-level Biosafety Primate Research Center,Institute of Medical Biology,Chinese Academy of Medical Sciences and Peking Union Medical College,Kunming 650031,China;University of Chinese Academy of Sciences,Beijing 100049,China;State Key Laboratory of Medical Molecular Biology,Department of Molecular Biology and Biochemistry,Institute of Basic Medical Sciences,Medical Primate Research Center,Neuroscience Cen-ter,Chinese Academy of Medical Sciences,School of Basic Medicine Peking,Union Medical College,Beijing 100005,China
SARS-CoV-2 impairs the disassembly of stress granules and promotes ALS-associated amyloid aggregation
Yichen Li;Shuaiyao Lu;Jinge Gu;Wencheng Xia;Shengnan Zhang;Shenqing Zhang;Yan Wang;Chong Zhang;Yunpeng Sun;Jian Lei;Cong Liu;Zhaoming Su;Juntao Yang;Xiaozhong Peng;Dan Li-Bio-X Institutes,Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders,Ministry of Education,Shanghai Jiao Tong University,Shanghai 200030,China;School of Life Sciences and Biotechnology,Shanghai Jiao Tong University,Shanghai 200030,China;National Kunming High-level Biosafety Primate Research Center,Institute of Medical Biology,Chinese Academy of Medical Sciences and Peking Union Medical College,Kunming 650031,China;State Key Laboratory of Medical Molecular Biology,Chinese Academy of Medical Sciences,School of Basic Medicine,Peking Union Medical College,Beijing 100005,China;Interdisciplinary Research Center on Biology and Chemistry,Shanghai Institute of Organic Chemistry,Chinese Academy of Sciences,Shanghai 201210,China;University of Chinese Academy of Sciences,Beijing 100049,China;State Key Laboratory of Biotherapy,Department of Geriatrics and National Clinical Research Center for Geriatrics,West China Hospital,Sichuan University,Chengdu 610041,China;State Key Laboratory of Medical Molecular Biology,Department of Biochemistry and Molecular Biology,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100005,China;Bio-X-Renji Hospital Research Center,Renji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200240,China;Zhangjiang Institute for Advanced Study,Shanghai Jiao Tong University,Shanghai 200240,China
FTO stabilizes MIS12 and counteracts senescence
Sheng Zhang;Zeming Wu;Yue Shi;Si Wang;Jie Ren;Zihui Yu;Daoyuan Huang;Kaowen Yan;Yifang He;Xiaoqian Liu;Qianzhao Ji;Beibei Liu;Zunpeng Liu;Jing Qu;Guang-Hui Liu;Weimin Ci;Xiaoqun Wang;Weiqi Zhang-State Key Laboratory of Brain and Cognitive Science,CAS Center for Excellence in Brain Science and Intelligence Technology,Institute of Brain-Intelligence Technology(Shanghai),Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China;State Key Laboratory of Membrane Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China;University of Chinese Academy of Sciences,Beijing 100049,China;Institute for Stem Cell and Regeneration,Chinese Academy of Sciences,Beijing 100101,China;Beijing Institute for Stem Cell and Regenerative Medicine,Beijing 100101,China;CAS Key Laboratory of Genomic and Precision Medicine,Beijing Institute of Genomics,Chinese Academy of Sciences,Beijing 100101,China;China National Center for Bioinformation,Beijing 100101,China;Advanced Innovation Center for Human Brain Protection,and National Clinical Research Center for Geriatric Disorders,Xuanwu Hospital,Capital Medical University,Beijing 100053,China;Aging Translational Medicine Center,International Center for Aging and Cancer,Xuanwu Hospital,Capital Medical University,Beijing 100053,China;Chongqing Renji Hospital,University of Chinese Academy of Sciences,Chongqing 400062,China;Sino-Danish College,University of Chinese Academy of Sciences,Beijing 101408,China;State Key Laboratory of Stem Cell and Reproductive Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China;Beijing Institute for Brain Disorders,Beijing 100069,China
Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2
Yunqing Gu;Jun Cao;Xinyu Zhang;Hai Gao;Yuyan Wang;Jia Wang;Juan He;Xiaoyi Jiang;Jinlan Zhang;Guanghui Shen;Jie Yang;Xichen Zheng;Gaowei Hu;Yuanfei Zhu;Shujuan Du;Yunkai Zhu;Rong Zhang;Jianqing Xu;Fei Lan;Di Qu;Guoliang Xu;Yun Zhao;Dong Gao;Youhua Xie;Min Luo;Zhigang Lu-The Fifth People's Hospital of Shanghai,the Shanghai Key Laboratory of Medical Epigenetics,the International Co-laboratory of Medical Epigenetics and Metabolism,Ministry of Science and Technology,Institutes of Biomedical Sciences,Shanghai Institute of Infectious Diseases and Biosecurity,Shanghai Medical College,Fudan University,Shanghai,China;Institute of Pediatrics,Children's Hospital of Fudan University,Shanghai,China;Zhongshan-Xuhui Hospital,Fudan University,Shanghai,China;Key Laboratory of Medical Molecular Virology (MOE/MOH),School of Basic Medical Sciences,Shanghai Institute of Infectious Diseases and Biosecurity,Shanghai Medical College,Fudan University,Shanghai,China;State Key Laboratory of Molecular Biology,CAS Center for Excellence in Molecular Cell Science,Institute of Biochemistry and Cell Biology,Shanghai Institutes for Biological Sciences,Chinese Academy of Sciences,Shanghai,China;State Key Laboratory of Cell Biology,Shanghai Key Laboratory of Molecular Andrology,CAS Center for Excellence in Molecular Cell Science,institute of Biochemistry and Ceil Biology,Shanghai institutes for Biological Sciences,Chinese Academy of Sciences,Shanghai,China;Shanghai Public Health Clinical Center,Fudan University,Shanghai,China
Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
Jun Lan;Xinheng He;Yifei Ren;Ziyi Wang;Huan Zhou;Shilong Fan;Chenyou Zhu;Dongsheng Liu;Bin Shao;Tie-Yan Liu;Qisheng Wang;Linqi Zhang;Jiwan Ge;Tong Wang;Xinquan Wang-The Ministry of Education Key Laboratory of Protein Science,Beijing Advanced Innovation Center for Structural Biology,Beijing Frontier Research Center for Biological Structure,Collaborative Innovation Center for Biotherapy,School of Life Sciences,Tsinghua University,Beijing,China;Microsoft Research Asia,Beijing,China;Shanghai Synchrotron Radiation Facility,Shanghai Advanced Research Institute,Chinese Academy of Sciences,Shanghai,China;Department of Chemistry,Tsinghua University,Beijing,China;Center for Global Health and Infectious Diseases,Comprehensive AIDS Research Center,and Beijing Advanced Innovation Center for Structural Biology,School of Medicine,Tsinghua University,Beijing,China
Selection and structural bases of potent broadly neutralizing antibodies from 3-dose vaccinees that are highly effective against diverse SARS-CoV-2 variants,including Omicron sublineages
Lei Wang;Wangjun Fu;Linlin Bao;Zijing Jia;Yuxia Zhang;Yunjiao Zhou;Wei Wu;Jianbo Wu;Qianqian Zhang;Yidan Gao;Kang Wang;Qiao Wang;Chuan Qin;Xiangxi Wang-CAS Key Laboratory of Infection and Immunity,National Laboratory of Macromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing,China;University of Chinese Academy of Sciences,Beijing,China;Key Laboratory of Human Disease Comparative Medicine,Chinese Ministry of Health,Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases,Institute of Laboratory Animal Science,Chinese Academy of Medical Sciences and Comparative Medicine Center,Peking Union Medical College,Beijing,China;Changping Laboratory,Beijing,China;Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS),Shanghai Institute of Infectious Disease and Biosecurity,Shanghai Frontiers Science Center of Pathogenic Microbes and Infection,School of Basic Medical Sciences,Shanghai Medical College,Fudan University,Shanghai,China
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron
Huan Ma;Xinghai Zhang;Peiyi Zheng;Peter H.Dube;Weihong Zeng;Shaohong Chen;Qingyu Cheng;Yunru Yang;Yan Wu;Junhui Zhou;Xiaowen Hu;Yan Xiang;Huajun Zhang;Sandra Chiu;Tengchuan Jin-Department of Pulmonary and Critical Care Medicine,The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei,Anhui,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan,Hubei,China;Laboratory of Structural Immunology,CAS Key Laboratory of Innate Immunity and Chronic Disease,Hefei National Laboratory for Physical Sciences at Microscale,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei,Anhui,China;Department of Microbiology,Immunology and Molecular Genetics,University of Texas Health Science Center at San Antonio,San Antonio,TX,USA;University of Chinese Academy of Sciences,Beijing,China;Institute of Health and Medicine,Hefei Comprehensive National Science Center,Hefei,Anhui,China
A broadly neutralizing antibody against SARS-CoV-2 Omicron variant infection exhibiting a novel trimer dimer conformation in spike protein binding
Yingdan Wang;Wuqiang Zhan;Jiangyan Liu;Yanqun Wang;Xiang Zhang;Meng Zhang;Lin Han;Yunping Ma;Lu Lu;Yumei Wen;Zhenguo Chen;Jincun Zhao;Fan Wu;Lei Sun;Jinghe Huang-Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS)and Shanghai Institute of Infectious Disease and Biosecurity,Shanghai Fifth People's Hospital,Shanghai Public Health Clinical Center,Institutes of Biomedical Sciences,School of Basic Medical Sciences,Fudan University,Shanghai,China;Shanghai Immune Therapy Institute,Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital,Shanghai,China;State Key Laboratory of Respiratory Disease,National Clinical Research Center for Respiratory Disease,Guangzhou Institute of Respiratory Health,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou,Guangdong,China;Institute of Infectious Disease,Guangzhou Eighth People's Hospital of Guangzhou Medical University,Guangzhou,Guangdong,China
A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors
Peng-xuan Ren;Wei-juan Shang;Wan-chao Yin;Huan Ge;Lin Wang;Xiang-lei Zhang;Bing-qian Li;Hong-lin Li;Ye-chun Xu;Eric H.Xu;Hua-liang Jiang;Li-li Zhu;Lei-ke Zhang;Fang Bai-School of Life Science and Technology,and Shanghai Institute for Advanced Immunochemical Studies,ShanghaiTech University,Shanghai 201210,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan 430071,China;CAS Key Laboratory of Receptor Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;State Key Laboratory of Bioreactor Engineering,Shanghai Key Laboratory of New Drug Design,School of Pharmacy,East China University of Science and Technology,Shanghai 200237,China;Department of Chemistry,Imperial College London,London,United Kingdom;University of Chinese Academy of Sciences,Beijing 100049,China
Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates
Yi Wang;Sui Fang;Yan Wu;Xi Cheng;Lei-ke Zhang;Xu-rui Shen;Shuang-qu Li;Jian-rong Xu;Wei-juan Shang;Zhao-bing Gao;Bing-qing Xia-CAS Key Laboratory of Receptor Research,Stake Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan 430071,China;Academy of Integrative Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of Pharmacology and Chemical Biology,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Zhongshan Institute of Drug Discovery,Institution for Drug Discovery Innovation,Chinese Academy of Science,Zhongshan 528400,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。